Perfromance Wealth Partners, LLC Amgen Inc Transaction History

Perfromance Wealth Partners, LLC

$2.89 Billion
Q3 2024

A detailed history of Perfromance Wealth Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 6,436 shares of AMGN stock, worth $1.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,436

Previous 2,135 201.45%

Holding current value

$1.7 Million

Previous $667,000 210.79%

% of portfolio

0.07%

Previous 0.02%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$309.38 - $337.38 $1.33 Million - $1.45 Million	4,301 Added 201.45%	6,436 $2.07 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $7.25 Million - $8.81 Million	-27,604 Reduced 92.82%	2,135 $667,000
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $41,405 - $49,982	-154 Reduced 0.52%	29,739 $8.46 Million
Q4 2023 Jan 22, 2024	SELL	$255.7 - $288.46 $102,024 - $115,095	-399 Reduced 1.32%	29,893 $8.61 Million
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $233,518 - $289,919	1,068 Added 3.65%	30,292 $8.14 Million
Q2 2023 Jul 13, 2023	BUY	$214.27 - $253.37 $54,210 - $64,102	253 Added 0.87%	29,224 $6.49 Million
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $437,806 - $533,612	1,939 Added 7.17%	28,971 $7 Million
Q4 2022 Jan 19, 2023	BUY	$229.03 - $291.01 $13,054 - $16,587	57 Added 0.21%	27,032 $0
Q3 2022 Oct 17, 2022	SELL	$224.46 - $253.15 $113,127 - $127,587	-504 Reduced 1.83%	26,975 $6.08 Million
Q2 2022 Jul 15, 2022	SELL	$230.71 - $256.74 $228,402 - $254,172	-990 Reduced 3.48%	27,479 $6.69 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $617,025 - $682,591	-2,814 Reduced 9.0%	28,469 $6.88 Million
Q4 2021 Feb 03, 2022	BUY	$198.88 - $227.6 $6.22 Million - $7.12 Million	31,283 New	31,283 $7.04 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.

Account

Perfromance Wealth Partners, LLC Amgen Inc Transaction History